Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 0.67% is 96% below its 5-year average of 17.15%, near the low end of its 5-year range (0.67%–22.39%).
94.98% below its 12-month average of 13.34%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
0.67%
RETURN ON ASSETS (ROA) AVG TTM
13.34%
RETURN ON ASSETS (ROA) AVG 3Y
15.53%
RETURN ON ASSETS (ROA) AVG 5Y
17.15%
RETURN ON ASSETS (ROA) AVG 10Y
14.96%
RETURN ON ASSETS (ROA) AVG 15Y
15.65%
RETURN ON ASSETS (ROA) AVG 20Y
15.68%
CURRENT VS TTM AVG
-94.98%
CURRENT VS 3Y AVG
-95.69%
CURRENT VS 5Y AVG
-96.09%
CURRENT VS 10Y AVG
-95.52%
CURRENT VS 15Y AVG
-95.72%
CURRENT VS 20Y AVG
-95.73%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-86.96%
vs the sector median at left
Waters Corporation
Market Cap
$30.13B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
Market Cap
$30.16B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$30.86B
Return on Assets (ROA)
17.35%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$29.33B
Return on Assets (ROA)
1.76%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
Market Cap
$31.90B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$31.90B
Return on Assets (ROA)
-6.14%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$32.06B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$26.79B
Return on Assets (ROA)
24.67%
TTM Avg
25.02%
3Y Avg
24.63%
5Y Avg
23.85%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $30.13B | 0.67% | 13.34% | 15.53% | 17.15% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 4.27% | 5.83% | 5.87% | 14.86% |
| Zoetis Inc. (ZTS)vs › | $30.86B | 17.35% | 17.37% | 16.33% | 15.33% |
| Medline Inc. (MDLN)vs › | $29.33B | 1.76% | 3.17% | 1.75% | 1.75% |
| Biogen Inc. (BIIB)vs › | $31.40B | 2.60% | 5.11% | 6.74% | 8.29% |
| DexCom, Inc. (DXCM)vs › | $31.90B | 15.49% | 11.04% | 9.26% | 8.83% |
| Centene Corp. (CNC)vs › | $31.90B | -6.14% | -2.29% | 0.04% | 0.75% |
| ResMed Inc. (RMD)vs › | $32.06B | 16.99% | 17.06% | 15.57% | 14.60% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.79B | 24.67% | 25.02% | 24.63% | 23.85% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 5.41% | 4.41% | 4.42% | 6.18% |
ROA
0.7%
ROE
1.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 12.66% |
| 2024-12-31 | 14.01% |
| 2023-12-31 | 13.88% |
| 2022-12-31 | 21.57% |
| 2021-12-31 | 22.39% |
| 2020-12-31 | 18.37% |
| 2019-12-31 | 23.16% |
| 2018-12-31 | 15.93% |
| 2017-12-31 | 0.38% |
| 2016-12-31 | 11.19% |
| 2015-12-31 | 11.01% |
| 2014-12-31 | 11.13% |
| 2013-12-31 | 12.59% |
| 2012-12-31 | 14.57% |
| 2011-12-31 | 15.90% |
| 2010-12-31 | 16.40% |
| 2009-12-31 | 16.95% |
| 2008-12-31 | 19.87% |
| 2007-12-31 | 14.25% |
| 2006-12-31 | 13.74% |
| 2005-12-31 | 14.13% |
| 2004-12-31 | 15.34% |
| 2003-12-31 | 15.11% |
| 2002-12-31 | 14.61% |
| 2001-12-31 | 12.91% |
| 2000-12-31 | 20.99% |
| 1999-12-31 | 20.93% |
| 1998-12-31 | 12.88% |
| 1997-12-31 | -1.50% |
| 1996-12-31 | -0.66% |
